BSE filing, NSE: PRISMMEDI. Summary written from the filing by ALFA Finder's alert engine.
Prism Medico and Pharmacy Ltd: key numbers
- Share price
- ₹35.05
- Market cap
- ₹47.54 Cr
- Revenue (annual)
- ₹2.44 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- -119.6×Sector 45.0×
- Promoter holding
- 29.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prism Medico and Pharmacy Ltd
All →Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31. This is a routine filing.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy Limited has informed that no interest, dividend, or principal is payable on non-convertible securities for the quarter ending December 31, 2026.
Prism Medico and Pharmacy Management Change
Prism Medico and Pharmacy Limited re-appointed Davender Singh as a Non-Executive Non-Independent Director. The company also updated its statutory and secretarial auditor appointments.
Prism Medico and Pharmacy Annual General Meeting
Prism Medico and Pharmacy held its 24th Annual General Meeting on September 19, 2026, to transact ordinary and special business, including various investment approvals.
Prism Medico and Pharmacy Annual Report
Prism Medico and Pharmacy Limited has filed its Annual Report for the financial year 2025-2026 in accordance with Regulation 34 of SEBI LODR Regulations.
Other board meeting date announcements
All →Sanco Trans Board Meeting Date
Sanco Trans scheduled a November 12, 2026 board meeting to consider unaudited half-year results for September 2026. The trading window is closed until November 16, 2026.
Auro Laboratories Board Meeting Date
Auro Laboratories scheduled a November 13, 2026 board meeting to approve unaudited September quarter results. The trading window stays closed until 48 hours after the meeting.
Abril Paper Tech Board Meeting Date
Abril Paper Tech will hold a board meeting on 5 November 2026 to consider unaudited half-year results for September 2026. The trading window stays closed until 48 hours after the results are released.
SJP Ultrasonics Board Meeting Date
SJP Ultrasonics intimated BSE of a board meeting on November 5, 2026 to approve unaudited half-year results and limited review report. Trading window reopens November 7, 2026, 48 hours after results.
Ambica Agarbathies & Aroma Industries Board Meeting Date
Ambica Agarbathies & Aroma Industries has notified a board meeting on 5 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The filing is an advance intimation, with the results not yet approved.
Minal Industries Board Meeting Date
Minal Industries scheduled a board meeting on November 05, 2026 to approve unaudited standalone and consolidated results for Q2 and H1 ended September 30, 2026. The trading window stays closed until 48 hours after the results declaration.